Results 221 to 230 of about 52,946 (303)
Prescription of Opioid Analgesics for Chronic Non-Cancer Pain in Germany despite Contraindications: Administrative Claims Data Analysis. [PDF]
Niemann A+11 more
europepmc +1 more source
Gender and Overdose Risk Factors Among Clients Entering Residential Treatment for Opioid Use
ABSTRACT Introduction The period post‐residential treatment for opioid use is associated with heightened risk of overdose. The current study aims to: (i) describe characteristics of men and women attending residential treatment for primary opioid use; (ii) identify classes of clients based on primary opioid and other substance/s of concern and (iii ...
Chloe J. Haynes+9 more
wiley +1 more source
This systematic review and meta‐analysis of 5 randomized controlled trials (n = 965) compares the safety profile of remimazolam versus propofol for sedation during ERCP. Remimazolam was associated with a significantly lower incidence of hypoxia, hypotension, and bradycardia.
In Jung Kim+3 more
wiley +1 more source
The impact of opioid versus non-opioid analgesics on postoperative pain level, quality of life, and outcomes in ventral hernia repair. [PDF]
Alzatari R, Huang LC, Poulose BK.
europepmc +1 more source
Abstract Aims Our objective was to explore the stigma experienced by people with lived experiences of both diabetes and homelessness. Methods This community‐based participatory research (CBPR) project was underpinned by a partnership between academic researchers and those with lived experience (co‐researchers).
Saania Tariq+10 more
wiley +1 more source
Abstract Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are highly effective antidiabetic and anti‐obesity agents. Recent development and optimisation of these agents includes biased agonism (selective activation of a downstream signalling pathway) of the GLP‐1 receptor, which has demonstrated greater weight‐lowering effects and improved insulin
Sabrina Wong+4 more
wiley +1 more source